Navigation Links
Icagen Board Beginning to Follow Xmark Direction

RIDGEFIELD, Conn., Feb. 2 /PRNewswire/ -- Xmark Opportunity Partners, LLC ("Xmark"), the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., has, in the past, sent letters to the Board of Directors of Icagen, Inc. (Nasdaq: ICGN) setting forth its dissatisfaction with the company's corporate governance, management and strategic direction. Xmark would like to take this opportunity to respond to the Form 8-K filed by the company on January 29, 2009.

While Xmark applauds the Compensation Committee of the Board of Directors for choosing to not pay cash bonuses to the company's executive officers for 2008, it believes that this is but a small step in the right direction. Xmark is pleased that cash bonuses for the company's executive officers for 2009 will be based, in part, on "building shareholder confidence." However, Xmark believes that there are additional steps that can be taken by the company to pare its cash-burn requirements. As Xmark has repeatedly pointed out to the company, these are challenging economic times; the Board of Directors should continue to tighten the company's economic belt for the coming years.

Xmark remains committed to monitoring its significant common stock investment in the company and remains hopeful that it can engage in productive dialogue with the company to help it maximize shareholder value by, among other things, pursuing strategic alternatives.

SOURCE Xmark Opportunity Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Xmark Sends Letters to Icagens Board of Directors: Questions Companys Leadership as Well as Motives Behind Adoption of Poison Pill
2. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
3. MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members
4. Elite Meetings International Names New Advisory Board
5. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
6. Shaklee Partners With U.S. Ski Team and U.S. Snowboarding in Preparation for the 2010 Games in Vancouver
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 9, 2009
8. Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board
9. Quest Diagnostics Board Authorizes $500 Million in Share Repurchases
10. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
11. PPGI Appoints Rick Strandlund to the Board of Directors
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: